Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Golar LNG
GLNG
$4.45B
| – | – |
-330,576
| Closed | -$17.5M | – |
|
3102
Globant
GLOB
$2.05B
| – | – |
-149,621
| Closed | -$6.9M | – |
|
3103
GameStop
GME
$12.9B
| – | – |
-34,438
| Closed | -$793K | – |
|
3104
Globus Medical
GMED
$10.1B
| – | – |
-63,487
| Closed | -$5.47M | – |
|
3105
Grocery Outlet
GO
$1.37B
| – | – |
-1,558,797
| Closed | -$11M | – |
|
3106
Gladstone Commercial Corp
GOOD
$496M
| – | – |
-57,392
| Closed | -$656K | – |
|
3107
Gaotu Techedu
GOTU
$559M
| – | – |
-51,283
| Closed | -$101K | – |
|
3108
Structure Therapeutics
GPCR
$1.53B
| – | – |
-304,934
| Closed | -$14.7M | – |
|
3109
Gorman-Rupp
GRC
$1.87B
| – | – |
-7,533
| Closed | -$468K | – |
|
3110
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$10.9B
| – | – |
-13,014
| Closed | -$2.13M | – |
|
3111
Grindr
GRND
$2.38B
| – | – |
-83,520
| Closed | -$1.01M | – |
|
3112
Global Ship Lease
GSL
$1.49B
| – | – |
-11,722
| Closed | -$436K | – |
|
3113
FerroAtlántica
GSM
$491M
| – | – |
-11,213
| Closed | -$46.2K | – |
|
3114
Hudbay
HBM
$10.1B
| – | – |
-290,618
| Closed | -$6.07M | – |
|
3115
Helen of Troy
HELE
$873M
| – | – |
-257,000
| Closed | -$3.71M | – |
|
3116
Houlihan Lokey
HLI
$10.3B
| – | – |
-116,331
| Closed | -$16.7M | – |
|
3117
Hamilton Lane
HLNE
$5.35B
| – | – |
-654,579
| Closed | -$65.1M | – |
|
3118
PUT
Hilton Worldwide Holdings Inc. Common Stock
HLT
$83B
| – | – |
-95,100
| Closed | -$28.9M | – |
|
3119
Horace Mann Educators
HMN
$2.15B
| – | – |
-37,674
| Closed | -$1.61M | – |
|
3120
The Honest Company
HNST
$566M
| – | – |
-20,809
| Closed | -$61.2K | – |
|
|
3121
DELISTED
Hologic
HOLX
| – | – |
-4,722,968
| Closed | -$357M | – |
|
3122
Home BancShares
HOMB
$6.06B
| – | – |
-10,343
| Closed | -$279K | – |
|
3123
HealthEquity
HQY
$8.45B
| – | – |
-835,072
| Closed | -$69.8M | – |
|
3124
CALL
Harmony Biosciences
HRMY
$1.98B
| – | – |
-64,600
| Closed | -$1.81M | – |
|
3125
HealthStream
HSTM
$883M
| – | – |
-15,033
| Closed | -$311K | – |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.